The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 200.00
Bid: 199.00
Ask: 200.00
Change: -3.00 (-1.48%)
Spread: 1.00 (0.503%)
Open: 200.00
High: 200.00
Low: 196.00
Prev. Close: 203.00
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Announcement of Audited Results

1 Oct 2013 07:00

RNS Number : 3314P
James Halstead PLC
01 October 2013
 



 

 1 October 2013

 

JAMES HALSTEAD PLC

PRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS

FOR THE YEAR ENDED 30 JUNE 2013

"Record dividends"

 

Key Figures

 

·

Revenue slightly reduced at £217.1 million (2012: £226.3 million) - down 4.1%

·

Profit before tax £41.2 million (2012: £42.7 million) - down 3.5%

·

Earnings per 5p ordinary share of 14.8p (2012: 14.7p) - up 1%

·

Final dividend per ordinary share proposed of 6.0p (2012: 5.5p) - up 9.1%

·

Strong cash inflow from operations of £42.1 million (2012: £37.3 million)

·

Nil net gearing

 

Mr Mark Halstead, Chief Executive, commenting on the results, said:

 

 "We have grown significantly in the last few years and though in this year like for like turnover is 1.1% behind last year this should not detract from the upward trend we have seen and are determined to exploit. We remain highly profitable and cash generative which underpins our ability and intention to continue our record of dividends."

 

Enquiries:

 

James Halstead:

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

Hudson Sandler:

Nick Lyon

Telephone: 020 7796 4133

Altium (Nominated Advisor):

Ben Thorne

Paul Chamberlain 

Telephone: 020 7484 4040

 

 

Arden Partners (Brokers):

Chris Hardie Telephone: 020 7614 5900

 

 

 

 

CHAIRMAN'S STATEMENT

 

 

Against challenging market conditions I can report a solid set of results.

 

Our revenue for the year is £ 217.1 million (2012: £ 226.3 million), a reduction of some 4.1% on last year.

 

Looking at the revenue more closely the turnover in the UK is 3.5% ahead of last year and encouraging indeed. Turnover though down overall, includes the effects of foreign currency translation and the cessation of the motorcycle accessories business (Phoenix) last year; excluding these the decline in turnover is 1.1%.

 

We continue to win significant new build projects around the world such as the Specsavers chain of stores in Sweden and the Wulanchabu Hospital in Inner Mongolia.

 

Dividend

 

Despite the modest decline in profit our earnings per share are slightly increased and our cash reserves remain robust and it is pleasing to report that the Board proposes, once again, an increased final dividend. The final dividend will be 6.0p (2012: 5.5p) representing a 9.1% increase which combined with the interim dividend, paid in June 2013, of 2.75p (2012: 2.5p) makes a total of 8.75p (2012: 8.0p) for the year, an increase of 9.4%.

 

Acknowledgements

 

Given the solid achievements in difficult market conditions it is my pleasure to extend our gratitude to our staff and customers for their continued support. Our companies received various accolades in the year voted for by end users including Best Vinyl Product (UK - Contract Flooring Association), Supplier of the Year (New Zealand - Flooring Xtra), and Sales Partner Awards (Germany - Architects AIT). Our special thanks for the recognition of our teams that these accolades represent.

 

Outlook

 

Whilst the seeds of recovery are apparent these continue to be difficult times. Government spending is restricted in many markets and "tough" is the best description of the current trading conditions. Our visibility of day to day progress in the refurbishment market is not extensive and major projects are keenly contested by all manufacturers. We have grown significantly in the last few years and though in this year like for like turnover is 1.1% behind last year this should not detract from the upward trend we have seen and are determined to exploit.

 

 

Geoffrey Halstead

Chairman

CHIEF EXECUTIVE'S REVIEW

 

 

In these challenging times, with recessionary pressures on many businesses, I am disappointed not to be able to report continued record revenue and profit. However, the last decade has seen turnover more than double and profit before tax treble. Our flooring business continues to be highly successful.

 

The James Halstead Group of companies is focused completely on flooring these days and the value of our flooring turnover in the core UK market has grown 3.5% year on year. Excluding the effects of currency translation and the cessation of the Phoenix motorcycle accessory business there is an underlying drop of 1.1% in our flooring sales.

 

Raw material prices were broadly in line with the prior year which was itself comparable with 2010-11: a year of record highs. That said, raw material prices are high for our competitors and the more pressing challenge is of industry wide excess capacity and the consequent battle to gain volume.

 

Overhead control continues to be important and we continue to focus on our costs.

 

Overall the fall in profit before tax was 3.5%, which, whilst disappointing, is the first fall for over a decade. The profit after tax is slightly ahead of last year at £ 30.6 million (2012: £ 30.5 million) and reflects the lower tax rates on profit in the UK relative to Germany and Australia.

 

Our gross margins increased as a percentage by ½%, caused mainly by the effects of volume growth in sheet vinyl flooring. The combined effects of various exchange rates largely offset each other and though there were monthly fluctuations in raw material prices these were generally flat over the year as a whole. There were fixed overhead increases in selling and distribution costs as a result of increased warehousing space, though these were mitigated by tight control of other costs. Administration costs were also reduced.

 

Cash stands at £34.9 million (2012: £38.7 million) even after the payment of £31.5 million in dividends, £11.4 million in tax and £3.7 million of capital expenditure. The cash inflow from operations remains strong at £42.1 million (2012: £37.3 million).

 

Polyflor Nordic comprising Polyflor Norway based in Oslo and Falck Design based in Sweden

 

Our Scandinavian businesses made good progress with Norway advancing sales 5.4% in local currency and our Swedish business by some 23%. These are positive moves indeed.

 

In Norway we have noted in recent months that there is an increase in the rate of new build and refurbishment particularly in the areas of healthcare and education and this should underpin continued progress. Polyflor Nordic recently supplied the new headquarters of the Milvern Departementat (the Department for the Environment) against keen competition. Falck have supplied the NKS Hospital and the Tele2 Arena, both in Stockholm.

 

The growth in our sheet vinyl sales is encouraging.

 

 

 

 

 

Objectflor and Karndean, our European based organisations located in Cologne

 

In local currency terms our central European based business achieved the same level of turnover as last year. This was an achievement in a very competitive market especially as the business grew 14.1% to a record level last year (again excluding exchange rate effects). Germany is a very large marketplace for vinyl flooring, most notably sheet vinyl, and as other parts of Europe suffer from the effects of governmental "belt-tightening" all manufacturers are looking to increase volumes in this area. Inevitably there was a degree of margin erosion and this combined with the launch of new designs and full year effect of the new 18,000 m² warehouse facility had an effect on the bottom line profitability of the business.

 

Notwithstanding the foregoing the growth in sales of sheet vinyl is encouraging as our competitors focus on the mature luxury vinyl tile (LVT) market. In the area of LVT our re-vamped Expona Commercial range was launched at the BAU exhibition in Munich and though facing some price pressure is trading well.

 

The company supplied flooring to the Jena (Germany) social housing renovation project which was one of the largest residential renovation projects in Europe last year and has been the major flooring partner in the Weissenhäuser Strand development, a major holiday park on the Baltic Sea at Kiel.

 

Polyflor Pacific - encompassing Australia, New Zealand and Asia

 

In Hong Kong and Oriental Asia sales were some 8% ahead of last year with a degree of margin improvement. China in particular continues to trade well. This is encouraging because this emerging market is still, for us, an area of new build project rather than refurbishment and every manufacturer wants these volumes. To the extent that we face European competitors the relative weakness of Sterling gives some competitive advantage, though our successes over the last 25 years present a very good CV for specifiers. What is also encouraging is that we remain competitive against our European and American competitors that have built factories in China - not only on price but on quality. This was evident in the sales we made relating to the 12th National Games of the People's Republic (recently held in Liaoning Province) where a good proportion of the facilities used Polyflor flooring.

 

Australia reported lower sales by some 11% which was largely as expected, as certain key large projects ended. Nevertheless, the company has seen good take up of its design flooring in the retail sector with chain stores such as "Wok-in-a-Box", "Foodtopia" and "SpendlessShoes" adopting our product for store refurbishment. Polyflor is also the standard for all trains and trams in Southern Australia and the core business is robust.

 

New Zealand, after many years in recession is showing signs of recovery and our turnover has increased, albeit by a modest 2%. Polyflor has secured the tender for all social housing through "Housing New Zealand", as well as supplying flooring to the last 7 hospital refurbishments and supplying safety flooring to the number 1 bus manufacturer, Designline. I am hopeful of continued growth, especially as the rebuilding work in Christchurch begins to ramp up.

 

 

Polyflor & Riverside Flooring, based in UK

 

A solid year for our UK operations in Teesside and Greater Manchester, with UK turnover increasing by 3.7%.

 

Profitability increased and these manufacturing facilities are the backbone of our sales activities around the globe. In the early part of the year we launched Polyflor Modena to the UK trade to set the standard for design effect in safety flooring and the sales have been encouraging. During the year we augmented this with the first "luxury vinyl sheet" aimed at adding to the success of luxury vinyl tile by offering a loose lay design sheet of contract quality to the social housing sector. This added the option of 3m and 4m wide product in addition to the standard 2m and though only launched in May 2013 is, to date, proving to be a success.

 

In terms of major investment plans for our plant there is little to report. We have upgraded line speed and line capability and will continue to implement engineering solutions to improve conversion, reduce energy waste and improve output but the "big ticket" items are fully paid for and the focus is on extracting the returns for these investments. The slowdown in overseas market leads us to manufacture within our capacity and is, to a degree, hampering productivity but this is, hopefully, a short term problem that will reverse.

 

Our business manufactures and sources vinyl floor covering and though the majority of sales are manufactured in house there is an important fraction from elsewhere, most notably China.

 

Whilst we do not own a factory in China, the Company takes a hands-on approach when sourcing product to ensure high manufacturing standards and product quality. We believe that for many companies that source in China, the key motivation is to minimise costs. Often this comes at the cost of responsible environmental manufacturing and product quality.

 

Many of our end customers are connected to government-sponsored contracts. The reputation that we build in the market is vitally important to us and will underpin our success in the future.

 

In 2005, we worked with our manufacturing partner in China to ensure they were accredited to ISO 14001 in respect of environmental standards. We continue to drive for "best in class" accreditation across the board and have recently achieved the BES 6001 standard, which is an independent verification of responsible outsourcing. Our manufacturing partner is the only vinyl flooring factory in China to achieve this accreditation. This demonstrates clearly the serious approach we take to corporate social responsibility in this geography.

 

 

Outlook

 

There are signs of recovery, but these are patchy. Our markets remain solid but missing that key confidence that growth has returned. I am confident that our portfolio and our commercial reputation will hold us in good stead but cannot predict that there will be significant growth in the short term.

 

Innovation continues to be a feature of our business having developed and patented two new safety floors - acoustic safety floor and LVT safety floor. These have already been sampled and tested in situ and are in the process of full launch to our customers. These, and range updates will help us to maintain margins against the competitors.

 

In short, it is a time keep heads down and plough on, defending the position we have achieved, and I am confident of another set of solid results to come.

 

 

 

 

Mark Halstead

Chief Executive

 

 

Audited Consolidated Income Statement

for the year ended 30 June 2013

 

Year

ended

30.06.13

£'000

Year

ended

30.06.12

£'000

Revenue

217,082

226,335

Cost of sales

(126,799)

(133,013)

Gross profit

90,283

93,322

Selling and distribution costs

(39,877)

(38,723)

Administration expenses

(9,715)

(12,386)

Operating profit

40,691

42,213

Finance income

3,146

3,821

Finance cost

(2,628)

(3,327)

Profit before income tax

41,209

42,707

Income tax expense

(10,610)

(12,176)

Profit for the period attributable to equity shareholders

30,599

30,531

Earnings per ordinary share of 5p:

-basic

14.8p

14.7p

-diluted

14.7p

14.7p

 

 

 

 

 

Audited Consolidated Balance Sheet

as at 30 June 2013

As at

30.06.13

£'000

As at

30.06.12

£'000

Non-current assets

Property, plant and equipment

33,391

31,693

Intangible assets

3,232

3,232

Deferred tax assets

5,545

5,362

42,168

40,287

Current assets

Inventories

56,761

52,452

Trade and other receivables

33,158

30,962

Derivative financial instruments

827

1,067

Cash and cash equivalents

34,866

38,704

125,612

123,185

Current liabilities

Trade and other payables

55,903

49,645

Derivative financial instruments

63

654

Current income tax liabilities

5,647

6,962

61,613

57,261

Net current assets

63,999

65,924

Non-current liabilities

Retirement benefit obligations

13,902

10,367

Deferred tax liabilities

815

850

Borrowings

200

200

Other payables

454

456

15,371

11,873

Net assets

90,796

94,338

Equity

Equity share capital

10,335

5,164

Equity share capital (B shares)

160

160

10,495

5,324

Share premium account

2,101

1,974

Retained earnings

70,977

75,324

Other reserves

7,223

11,716

Total equity attributable to shareholders of the parent

 

90,796

 

94,338

 

 

Audited Consolidated Cash Flow Statement

for the year ended 30 June 2013

 

Year

ended

30.06.13

£'000

Year

ended

30.06.12

£'000

Cash inflow from operations

42,147 

37,251 

Interest received

394 

277 

Interest paid

(67)

(100)

Taxation paid

(11,353)

(10,212)

Cash inflow from operating activities

31,121 

27,216 

Purchase of property, plant and equipment

(3,731)

(2,885)

Proceeds from disposal of property, plant and equipment

242 

368 

Cash outflow from investing activities

(3,489)

(2,517)

Equity dividends paid

(31,518)

(15,381)

Purchase of own shares

Shares issued

-

131 

(5,156)

909 

Cash outflow from financing activities

(31,387)

(19,628)

Net (decrease)/increase in cash and cash equivalents

(3,755)

5,071 

Effect of exchange differences

(83)

(398)

Cash and cash equivalents at start of year

38,704 

34,031 

Cash and cash equivalents at end of year

34,866 

38,704 

 

 

Audited Consolidated Statement of Comprehensive Income

for the year ended 30 June 2013

 

Year

ended

30.06.13

£'000

Year

ended

30.06.12

£'000

 

Profit for the year

 

30,599 

 

30,531 

 

 

Other comprehensive income

 

Items that will not be reclassified subsequently to the income statement :

 

Actuarial loss on the defined benefit pension scheme (net of tax)

Deferred taxation - change of rate  

 

(3,463)

35 

 

(580)

71 

(3,428)

(509)

 

Items that could be reclassified subsequently to the income statement:

 

Foreign currency translation differences

 

(93)

 

(1,851)

Fair value movements on hedging instruments

767 

144 

674 

(1,707)

Total comprehensive income for the year

27,845 

28,315 

 

Attributable to equity holders of the

 Company

27,845 

28,315 

 

 

 

 

NOTES

 

 

 

1.

The final dividend of 6p per ordinary share will be paid on 6 December 2013 to shareholders on the register as at 8 November 2013. The full report and accounts will be posted to shareholders on 25 October 2013.

 

2.

The financial information in this statement does not represent the statutory accounts of the Group. Statutory accounts for the year ended 30 June 2012 have been delivered to the Registrar of Companies, carrying an unqualified audit report and no statement under section 498 (2) or (3) of the Companies Act 2006.

 

3.

Statutory accounts for the year ended 30 June 2013 have not yet been delivered to the Registrar of Companies. They will carry an unqualified audit report and no statement under section 498 (2) or (3) of the Companies Act 2006.

 

4.

Earnings per ordinary share

 

2013

2012

£'000

£'000

 

 

Profit for the year attributable to equity shareholders

30,599

30,531

 

 

Weighted average number of shares in issue

206,643,767

207,325,750

 

 

Dilution effect of outstanding share options

954,657

860,410

 

 

Diluted weighted average number of shares

207,598,424

208,186,160

 

 

 

Basic earnings per ordinary share

14.8p

14.7p

 

 

Diluted earnings per ordinary share

14.7p

14.7p

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR URONROSAKOAR
Date   Source Headline
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results
2nd Feb 20237:00 amRNSTrading Update
1st Dec 20224:36 pmRNSResults of Annual General Meeting
1st Dec 20227:00 amRNSChairman’s Statement to the Annual General Meeting
14th Oct 20225:46 pmRNSPosting of Annual R&A and Notice of AGM
3rd Oct 20227:00 amRNSPreliminary Results
14th Sep 20221:01 pmRNSNotice of Preliminary Results
16th Aug 20223:59 pmRNSPDMR Exercise of Share Options
10th Aug 20224:00 pmRNSPDMR Grant of Share Options
1st Aug 20227:00 amRNSTrading Update
13th Jul 202211:24 amRNSBlock Listing Six Monthly Return
5th May 202210:48 amRNSTR-1: Notification of Major Holdings
31st Mar 20227:00 amRNSInterim Results
1st Feb 20227:00 amRNSTrading Update
17th Jan 202211:00 amRNSTotal Voting Rights and Application for Listing
13th Jan 20222:50 pmRNSApplication for Bonus Shares
7th Jan 20229:36 amRNSBlock Listing Six Monthly Return
7th Jan 20229:32 amRNSTotal Voting Rights
18th Nov 202111:13 amRNSResults of Annual General Meeting
18th Nov 20217:00 amRNSChairman’s Statement to the Annual General Meeting
15th Oct 20214:00 pmRNSPosting of Annual R&A and Notice of AGM
4th Oct 20217:00 amRNSPreliminary Results
20th Sep 20212:46 pmRNSNotice of Preliminary Results
4th Aug 20217:00 amRNSTrading Update
14th Jul 20215:00 pmRNSBlock Listing Six Monthly Return
25th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20214:00 pmRNSPDMR Exercise of Share Options
31st Mar 20217:00 amRNSInterim Results
1st Feb 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSBlock Listing Six Monthly Return
12th Nov 202011:00 amRNSResults of Annual General Meeting
12th Nov 20207:00 amRNSChairman's Statement to the Annual General Meeting
16th Oct 20204:00 pmRNSPosting of Annual Report and Notice of AGM
1st Oct 20207:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.